论文部分内容阅读
目的:观察益气活血法辅助治疗乳腺癌术后患者的疗效及对患者生存质量的影响。方法:选择2011年4月~2013年4月我院收治的乳腺癌术后患者60例,将其随机分为观察组和对照组,每组30例,对照组采用TAC化疗方案,观察组在对照组基础上加用我院自拟中药方剂,比较两组临床疗效、生存质量以及不良反应。结果:观察组治疗总有效率56.67%、对照组治疗总有效率30.00%,两组比较,差异具有统计学意义(P<0.05);治疗前两组患者生存质量评分不具有统计学显著性意义(P>0.05),治疗后两组患者生存质量评分均较治疗前显著升高(P<0.05),治疗后观察组生存质量评分显著高于对照组(P<0.05);观察组患者恶心呕吐、肝功能损害的发生率显著低于对照组(P<0.05)。结论:益气活血法辅助治疗乳腺癌术后化疗患者能够显著提高临床疗效,且有效改善患者生存质量、减少化疗毒副反应,值得临床运用。
Objective: To observe the effect of supplementing qi and promoting blood circulation in adjuvant treatment of postoperative patients with breast cancer and its impact on quality of life of patients. Methods: From April 2011 to April 2013, 60 patients with breast cancer who were admitted to our hospital from April 2011 to April 2013 were randomly divided into observation group and control group, with 30 cases in each group. TAC chemotherapy was used in the control group, On the basis of the control group, we used our own prescriptions to compare the clinical efficacy, quality of life and adverse reactions in the two groups. Results: The total effective rate was 56.67% in the observation group and 30.00% in the control group. There was significant difference between the two groups (P <0.05). The quality of life scores of the two groups before treatment were not statistically significant (P> 0.05). After treatment, the quality of life scores of both groups were significantly higher than those before treatment (P <0.05), after treatment, the quality of life scores of the observation group were significantly higher than those of the control group (P <0.05) , The incidence of liver damage was significantly lower than the control group (P <0.05). Conclusion: The adjuvant therapy of Yiqi Huoxue Therapy for postoperative chemotherapy of breast cancer patients can significantly improve the clinical efficacy, and effectively improve the quality of life of patients, reduce the side effects of chemotherapy, it is worth clinical application.